Abbreviations & Acronyms 3-D = three-dimensional AUC = area under curve CT = computed tomography HU = Hounsfield units MSD = mean stone density NA = not available PCNL = percutaneous nephrolithotomy ROI = region of interest SHI = stone heterogeneity index SSD = skin-to-stone distance SWL = shock wave lithotripsy URS = ureteroscopy VCSD = variation coefficient of stone density Objectives: The objective of the present study was to investigate the usefulness of three-dimensional images of stones to measure mean stone density for predicting the outcome of shock wave lithotripsy. Methods: We retrospectively identified 239 patients who underwent shock wave lithotripsy with pretreatment non-contrast computed tomography. We automatically measured the mean stone density of three-dimensional images of stones using a highfunctional viewer. For comparison, mean stone density was also measured by two previously reported techniques using both the abdominal windows and the bone windows on the axial slice at the level of the largest diameter of the stone. We compared the outcome predictive power after the first treatment with outcomes according to measurement by four other methods. We also carried out logistic regression analysis, including mean stone density measured by three-dimensional images. Results: The single treatment success rate was 48.5%. The effect size (14.148) of the mean stone density measured by three-dimensional images was higher than those of the other four manual methods. In addition, the area under the curve (0.6330) of the mean stone density measured by three-dimensional images was significantly higher than those of the other methods. Increasing stone volume (P = 0.002) and increasing mean stone density measured by three-dimensional images (P = 0.023) were significant independent predictors of the treatment outcome on multivariate analysis. Conclusions: This is the first study to compare the predictive powers for shock wave lithotripsy outcome of various mean stone density measuring methods. There is an indication that mean stone density automatically measured by three-dimensional images of stones is more useful than other measuring methods for predicting outcomes of shock wave lithotripsy.
Introduction
Extracorporeal SWL is the first-line treatment choice for upper urinary tract calculi. It has advantages of safety and non-invasiveness over URS or PCNL. [1] [2] [3] Compared with the other therapies, however, SWL has a lower treatment success rate. 4 Its failure could contribute to prolonged ureteral obstruction, recurring symptoms and additional therapy cost. It is therefore important to identify predictive factors for SWL outcome and to make a suitable treatment plan for patients with upper urinary tract calculi.
Recently, several studies have assessed the predictive SWL success of non-contrast CT parameters, such as SSD, MSD, SHI and VCSD. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] MSD is widely recognized as a significant predictor of SWL outcome among these parameters. Patients with MSD >900-1000 HU have less successful SWL results, according to the American Urological Association guidelines. 21 However, to our knowledge, consensus has not been reached on how MSD should be measured. Various MSD measuring methods have been reported in previous studies, but measured MSD value varies depending on how it is measured. 7, 8, 10, 11, 14, 18, 19 Manual measuring methods could also lead to measurement bias between individuals doing the measurements.
Furthermore, MSD measured on a single axial image might not reflect the mean density of the entire stone.
We hypothesize that MSD automatically measured by 3-D stone images using a high-functional viewer can achieve better reproducibility and accuracy in predicting SWL outcome than other means of measurement. We compare the predictive power of 3-D images with various other measuring methods, including those previously reported, using the outcomes of a single SWL session. We elucidate the usefulness of 3-D images of urinary tract calculi in the measurement of MSD.
Methods Patients
We retrospectively reviewed the records of consecutive patients who underwent extracorporeal SWL for their radiopaque renal and ureteral calculi at the Wakayama Medical University Hospital, Wakayama, Japan, between January 2008 and January 2016. Excluded from the present study were patients who did not undergo pretreatment non-contrast CT examination, those who were not followed up at our hospital, those who underwent SWL for pretreatment for URS or PCNL and those whose treatment outcomes could not be ascertained. Of 347 candidates, 239 patients were finally enrolled in the present study. All participants underwent pretreatment non-contrast CT (5-mm collimation width using a LightSpeed 64-slice multidetector helical CT scanner (GE Healthcare Technologies, Waukesha, WI, USA) at 0.5 s per rotation (120 kV and 100 mA)). This retrospective study was approved by the Wakayama Medical University institutional review board (approval number 1887).
Treatment
All patients underwent SWL using Lithotripter S (Dornier MedTech, Wessling, Germany), and were treated with up to a maximum of 3000 shocks for renal and upper ureteral stones, and up to 4000 shocks for mid and distal ureteral stones with a gradual augmentation of power at 70 shocks per min. The intensity of shock waves was left to the discretion of a physician. Stones were targeted with fluoroscopy at regular intervals during treatment.
Predictors
We retrospectively collected patient demographic data (age and sex) and clinical data (stone location, stone volume, MSD, SSD, urinary tract infection, hydronephrosis and urinary drainage). Urinary tract infection was defined as the presence of both leukocytes ≥5/high power field in urinary sediment examination and positive urine culture. We evaluated stone volume, MSD, SSD and the presence of hydronephrosis by non-contrast CT. A single radiologist reviewed all non-contrast CTs, and determined SSD and the presence of hydronephrosis using a WebPACS system. SSD was defined as the mean vertical distance from the center of the stone to the skin measured on a supine non-contrast CT image at 0°, 45°and 90°, as suggested by Pareek et al.
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Stone volume and MSD were automatically measured using the Aquarius iNtuition Viewer (TeraRecon Inc., Foster City, CA, USA), a high-functional viewer that allows physicians to carry out advanced 3-D image analysis of lesions. We extracted 3-D stone images of lesions ≥100 HU, and measured stone volume and MSD of the entire stone (Fig. 1) . We roughly designated the area including the stone without including surrounding calcification or bone tissue on each axial CT image and clicked the "extraction" button after setting the threshold value at 100 HU. By this operation, 3-D stone images were extracted, and stone volume and MSD of the entire stone were measured automatically. This measurement was carried out by three radiologists and an average of these measurements was calculated.
MSD was also measured by two previously reported techniques using both the abdominal windows and the bone windows on the axial slice at the level of the largest diameter of the stone. 8 In one method, the elliptical ROI incorporated the stone as a treatment object without including adjacent soft tissue (Fig. 2a) . In the other method, MSD was calculated from three consistent (area 0.005 cm 2 ), small, non-overlapping ROI chosen for each stone. In this method, a small ROI is placed at the center, the edge and the middle of the two points on each stone (Fig. 2b) . These manual measurements were also carried out by three radiologists and an average of these measurements was calculated.
Outcomes
We defined significant residual stones as residual fragments ≥4 mm in maximum diameter. SWL outcome was determined using non-contrast CT within 3 months after first SWL treatment. SWL success was defined as the absence of significant residual stones. Patients who required re-treatment or adjunctive treatment (URS, PCNL, ureteral stenting or nephrostomy tube placement) were deemed unsuccessful cases. 
Statistical analysis
We carried out statistical comparison of patient demographics and stone parameters using v 2 -tests and t-tests. In addition, MSD measured by various measurement methods were compared between successful and unsuccessful groups, with effect size calculated as Cohen's D. We constructed receiver operating characteristic curves to compare the predictive powers for SWL outcome between various MSD measurement methods. Furthermore, the median range was calculated, the difference between the maximum value and minimum value of MSD was measured by three measurers using each measuring method. We carried out univariate and multivariate analyses to identify factors contributing to significant residual stones after the first SWL session in logistic regression analysis. For all statistical tests, the significance threshold was P < 0.05. We carried out statistical analyses using JMP Pro 12 (SAS Institute, Cary, NC, USA).
Results
Overall patient demographics and stone parameters are summarized in Table 1 . The mean age was 59.3 years and 158 patients (66%) were male. Of the 239 patients, 94 patients (39%) were treated for kidney stones. The mean stone volume was 627.9 mm 3 . The mean MSD measured by 3-D image, elliptical ROI in abdominal windows, three ROIs in abdominal windows, elliptical ROI in bone windows and three ROIs in bone windows were 418.4 HU, 706.8 HU, 731.4 HU, 896.1 HU and 909.7 HU, respectively (Table 2) .
In total, 116 and 123 patients were classified as the successful and unsuccessful groups, respectively. Comparison of patient characteristics and stone parameters between the two groups is shown in Table 1 . Patients in the successful group had a statistically significantly younger age (P = 0.029), lower percentage of multiple stones (P = 0.019) and smaller stone volume (P < 0.001) than those in the unsuccessful group. Table 2 compares MSD by five measurement methods between the two groups. MSD in the successful group was significantly lower than that in the unsuccessful group according to all measuring methods. The effect size of the 3-D image (14.148) was the highest of the five measuring methods. The AUC of 3-D images for SWL outcome was 0.6330, significantly higher than that of either elliptical ROI in abdominal windows (0.5836, P = 0.006), average of three points in abdominal windows (0.5756, P = 0.004), elliptical ROI in bone windows (0.5797, P = 0.008) or average of three points in bone window (0.5794, P = 0.006; Table 3 ).
The median range of MSD measured by the three people using elliptical ROI in the abdominal windows was 73.9 HU Table 4 shows the results of univariate and multivariate logistic regression analyses of factors, including MSD measured by 3-D images, which predict residual stones after the first SWL session. Increasing age (P = 0.028), multiple stones (P = 0.017), increasing stone volume (P < 0.001) and increasing MSD (P < 0.001) were significantly associated with residual stones in univariate analysis. On multivariate analysis, increasing stone volume (P = 0.002) and increasing MSD (P = 0.023) were independent significant predictors of residual stones.
Stone composition was calcium oxalate in 97 patients (40.6%), apatite in six patients (2.5%), calcium oxalate and apatite in 50 patients (20.9%), uric acid in seven patients (2.9%), struvite in five patients (2.1%), other in three patients (1.3%) and unknown in 71 patients (29.7%).
Discussion
In the present study, we measured the MSD of 3-D stone images using a high-functional viewer, and compared the predictive powers for the outcome after a single SWL session between various MSD measuring methods. Our results show that the predictive power of MSD based on 3-D images for SWL outcome is stronger than that of MSD measured by other methods.
Previous studies showed that MSD is a useful parameter that affects SWL success. 8, 10 The American Urological Association guidelines state that MSD <900-1000 HU can help to predict success with SWL. 21 However, MSD measuring methods differ among studies (Table 5) . 7, 8, 10, 11, 14, 18, 19 Until now, the optimum MSD measuring method for predicting SWL outcome was not documented. The present study shows that MSD values measured by the various measuring methods Continuous variables are shown in mean AE SD form. were different ( Table 2) . CT image vision depends on the CT window setting; that is, abdominal windows or bone windows. MSD measured in bone windows were larger than that those measured in abdominal windows according to our results. This is probably because only regions with high CT attenuation value are visible in bone windows, different to abdominal windows. Measured MSD could also vary depending on the method of ROI placement. However, we found almost no difference in MSD values measured by two different means of ROI placement; that is, elliptical ROI and three ROIs. This might be because we set a rule that small ROIs needed to be placed at the center, the edge and between the two points of each stone, not completely randomly, when we calculated MSD from the average of three ROIs. In addition, manual measuring methods could lead to measuring bias between measurers. The establishment of an accurate and reproducible method for measuring MSD is necessary, as suggested by varied results. In the present study, we used 3-D stone images and automatic measurement of MSD by a high-functional CT viewer. Our results suggest that this measuring method has better reproducibility than the other four manual measuring methods.
In addition, MSD measured by 3-D images was found to have a stronger predictive power for SWL outcome in the present study than those measured by other measuring methods. The high-functional viewer enables relatively accurate measurement of CT attenuation value of entire stones, including the edge of stones. As shown in Figure 3 , CT attenuation value is generally found to be high in the central part of stones, and the value lowers as it deviates from the center. To accurately measure CT attenuation value of entire stones, the edge of stones must also be included in the measurement. However, because the image of the edge of stones is fogged owing to halation, it is difficult to accurately distinguish between stones and surrounding soft tissues by unaided vision. If we can completely distinguish between them, ROI does not always fit inside the stone, because stones are often irregular in shape. When we calculate the MSD from the average of three ROIs, there is variability depending on from where we choose to measure. The use of a high-functional viewer, by contrast, enables an image of entire stones, including the edge, using cut-off CT attenuation value.
A second reason for stronger predictive power for SWL outcome is that we can three-dimensionally measure MSD using a high-functional viewer. In most previous studies, MSD was measured two-dimensionally on the axial non-contrast CT image from the point of the largest stone diameter. However, CT attenuation value tends to be high in the central part of stones and low in the edge of stones also in the coronal images (Fig. 3) . Thus, for accurate measurement of the MSD of entire stones, it is necessary to measure the MSD three-dimensionally, rather than two-dimensionally. The reason why the MSD of 3-D stone images is significantly lower than the MSD measured by the other four manual measuring methods is the ability to include the stone edge with low CT attenuation value within the measuring area three-dimensionally. We therefore believe that measurement of the MSD by 3-D stone images is more accurate and reproducible for predicting SWL outcome than previously reported measuring methods.
Unfortunately, it is difficult to adjust the gap between MSD values measured by different measuring methods, and (a) (b) Fig. 3 Example of the distribution of CT attenuation value in stones on (a) the axial image and (b) the coronal image from the point of the largest diameter of a stone.
we cannot directly apply the results taken by the MSD of 3-D stone images to other manual measuring methods. However, we believe that the present study is meaningful in that our results highlight the problem that MSD measuring methods are not standardized in previous studies or in various guidelines. The present results also suggest that the MSD of 3-D stone images have a stronger predictive power for SWL outcome than those measured by other previously reported measuring methods. A further benefit of using the 3-D viewer is that it takes only a few minutes to measure the MSD of 3-D stone images. If the 3-D viewer becomes widely used in the future, automatic measurement of the MSD by 3-D stone images could be easily used in clinical practice and become the standard measuring method of the MSD. Based on the optimal cut-off point identified by our receiver operating characteristic analysis, stones with 3-D MSD >414 HU might be suited for endoscopic surgery rather than SWL. However, further prospective large multicenter studies are necessary to identify an optimal cut-off point of 3-D MSD that can be universally used. In addition, regardless of the method of measurement used, measurement errors of MSD due to halation are thought to be increased in the measurement of small stones. It will be necessary to carry out subgroup analysis by categorizing stone sizes in future large-scale studies. Furthermore, the measurement values associated with stone heterogeneity, such as SHI and VCSD, have been reported to be useful for predicting SWL outcome. 17, 20 We need to investigate the usefulness of these values based on 3-D stone images.
Several limitations of the present study should be acknowledged. First, this study was retrospectively undertaken at a single center. The number of patients included in this study, however, is comparable with previous reports. Second, this study does not consider the experience of the operator. As Okada et al. discussed the importance of technical training, SWL is a therapy affected not only by the CT value of the calculus, but also by the characteristics of the instrument and the skill of the operator. This limitation might explain why the SWL success rate of the present series is lower than that of other reports. 22 Third, the timing of SWL outcome evaluation was inconsistent, although SWL outcome was determined using non-contrast CT within 3 months after the first SWL treatment. Fourth, the upper limit of the shock wave number for renal stones and ureteral stones varied, and the intensity of the shock waves was left to the judgment of a physician. Although the shock wave number and the intensity of shock waves have not been fixed in most previous retrospective studies of SWL, these differences in treatment methods could influence treatment outcome. Finally, there is no evidence that 100 HU is the most suitable cut-off CT attenuation value for 3-D stone images. However, this value is appropriate, because substances with ≥100 HU in human bodies are generally bone, calculus and calcification only. A large-scale study is required to further overcome these limitations.
To our knowledge, this is the first study to compare the predictive powers for SWL outcome of various MSD measuring methods. Our results suggest that automatic measurement of MSD by 3-D stone images allows greater accuracy and reproducibility, so could be more useful than previously reported measuring methods for predicting SWL outcome.
